DeviceTalks Podcast Network

347 Episodes

Reverse

Hear closing arguments for attending DeviceTalks West and a preview of MedTech Innovator’s Finals

2024-10-1252:51

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi opens by making a strong case for MedTech people to attend DeviceTalks West, which is happening on Oct. 16-17. Go to West.DeviceTalks.com to register. MassDevice Editor Chris Newmarker brings his Newmarker’s Newsmakers – Women’s Health, Philiips, Nyxoah, CMR Surgical, and Johnson & Johnson MedTech. Finally, Paul Grand, CEO of MedTech Innovator, introduces DeviceTalks listeners to the five finalists who will compete for the 2024 Early-Stage Grand Prize. The winner will be voted for at the AdvaMed annual meeting in Toronto. Thank you for listening to the DeviceTalks Weekly Podcast Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Can Andromeda create an autonomous surgical robot? CEO Damiano makes case here and DeviceTalks West

2024-10-0501:02:58

In this week’s episode of the DeviceTalks Weekly Podcast, Nick Damiano, co-founder and CEO of Andromeda Surgical, previews his talk at DeviceTalks West by introducing listeners to the potential of autonomous surgery. Still early goings on, but Damiano paints and interesting picture of the future. If you want to see the future register at West.DeviceTalks.com. Speaking of the future, Host Tom Salemi speaks with Brody Galloway, a young MedTech professional who has turned his life’s healthcare experiences into a love of the industry and a drive to help. Anyone who wants to help should go to EnvisionMedtech.org. MassDevice Editor Chris Newmarker returns with his Newmarker’s Newsmakers – Surgical Robotics, Medtronic, ResMed, Layoffs and, of course, Baxter Healthcare. Thanks for listening to the DeviceTalks Podcast Network. Subscribe to the DeviceTalks Podcast Network so you don’t miss an episode of this or other industry-leading podcasts.

J&J MedTech’s John Murray and Dr. Berenstein on the early evolution of neurovascular treatments

2024-10-0156:54

In this episode of Neuro Innovation Talks, the newest podcast series in the DeviceTalks Podcast Network, the DeviceTalks editors invite Johnson & Johnson MedTech Neurovascular's Head of Global Marketing, John Murray to take over the podcast studio and bring to light the stories from the pioneering neurointerventionalists who have helped shape the stroke industry. In the first episode, Host John Murray sits down with Alejandro Berenstein, MD, Professor of Neurosurgery, Pediatrics and Radiology, Director of pediatric Cerebrovascular Surgery, Mount Sinai Health System, to discuss the incredible evolution of neurovascular surgery and its impact on modern healthcare. Dr. Berenstein shares his early inspirations, key breakthroughs, and the significant role mentors played in shaping his illustrious career. Highlighting landmark projects like the pioneering treatments for Vein of Galen Malformations (VOGM) and facial vascular anomalies, Dr. Berenstein shares the complexities and triumphs of his work. His story provides a blueprint for aspiring medical professionals and innovators, demonstrating how personal experiences, visionary thinking, and collaborative efforts can lead to groundbreaking advancements that significantly impact patient outcomes. Thank you to Zeus for sponsoring this episode of Neuro Innovation Talks. To learn more about how Zeus supports medical device companies, visit: www.zeusinc.com. Special thanks to the following for their support in the development of this podcast: Joanna Colangelo, Johanna Fifi, Whitney Garrett, Howard Riina, Lillian Medina, and J. Mocco. Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks to never miss an episode. Thank you for supporting the Neuro Innovation Talks podcast!

Can Biolinq shine new light on measuring glucose? CEO Yang makes a case here and at DeviceTalks West

2024-09-2745:54

Can Biolinq shine new light on measuring glucose? CEO Yang makes a case here and at DeviceTalks West In this podcast episode, Biolinq CEO Rich Yang reveals that he once vetoed his VC firm’s investment in the company. But something obviously changed his mind about the company’s novel approach to monitoring glucose and, hopefully, hormones and other critical elements. If you like what you hear, join us at DeviceTalks West where Yang will give a presentation about Biolinq’s unique technology. Register now at West.DeviceTalks.com and use the code DTPOD25 to save 25%. MassDevice Editor Chris Newmaker shares his Newmarker’s Newsmakers of the week - Route 92, Stryker Medtronic, Siemens Healthineers, Masimo and urology companies. Thank you for listening to the DeviceTalks Weekly podcast. Subscribe to the DeviceTalks Podcast Network.

Edwards surgical structural heart SVP Markowitz highlights culture, innovation, and making an impact

2024-09-2422:23

In this episode of Structural Heart Talks, Wayne Markowitz, General Manager and SVP, Surgical Structural Heart at Edwards Lifesciences, discussed the evolving landscape of the structural heart space, emphasizing the sharpened focus at Edwards under new leadership. Markowitz highlights the importance of the surgical structural heart business, with a strong emphasis on innovation and collaboration with cardiac surgeons. He emphasizes Edwards' 65-year legacy in innovation driven by partnerships with the surgical community, focusing on addressing unmet patient needs. The conversation also touched on the RESILIA portfolio, featuring surgical valves and conduits, and highlights ongoing clinical trials. Looking ahead, Markowitz shares his optimism about the future of the surgical structural heart business, emphasizing the need to bring more patients into the treatment system and the potential for growth in emerging markets. Thank you to Resonetics for sponsoring this episode of Structural Heart Talks. To learn more about how Resonetics supports medical device companies, visit: https://shorturl.at/E1wO8 Thank you for listening to the Structural Heart Talks podcast. Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks or the Structural Heart Talks on YouTube Podcasts to ensure you never miss an episode.

DeviceTalks West Keynote Endiatx CEO Torrey Smith on why he launched one of MedTech’s Moonshots

2024-09-2001:13:34

In this episode of the DeviceTalks Weekly, Host Tom Salemi interviews Endiatx CEO Torrey Smith, who will be the closing keynote speaker at the DeviceTalks West conference on Oct. 16-17 at the Santa Clara Convention Center. Smith talks about his journey into MedTech. Why he quit his job. And where his dream of building a swallowable surgical robot can lead him and his company. Register at West.DeviceTalks.com to see a demonstration of PillBot! Use the code DTPod25 to save 25%. In this week’s Newmarker’s Newsmakers, MassDevice Editor Chris Newmarker highlights the top MedTech stories of the week from Boston Scientific, Medtronic, Synchron, Shockwave (now part of Johnson & Johnson Medtech) and Masimo. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Abbott’s Jones-McMeans and Dr DeRubertis on PAD below-the-knee, LIFE-BTK trial & Esprit BTK approval

2024-09-1747:42

In this episode of AbbottTalks, Jennifer Jones-McMeans, PhD, Divisional VP of Global Clinical Affairs at Abbott and Brian DeRubertis, MD, Chief, Division of Vascular & Endovascular Surgery at Weill Cornell Medical Center tackle the complexities of treating peripheral arterial disease (PAD) below the knee, particularly chronic limb-threatening ischemia (CLTI), a severe form of PAD that drastically impacts patients' quality of life and longevity. In the episode, the two discuss Abbott's Esprit BTK System, the first-and-only FDA-approved drug-eluting resorbable scaffold for infrapopliteal CLTI. Dr. Jones-McMeans explains how Esprit BTK works by releasing a drug that prevents artery re-narrowing, crucial for maintaining sustained blood flow and promoting wound healing. Later, they walk us through the pivotal LIFE-BTK trial, a significant milestone that demonstrated Esprit's efficacy and led to its FDA approval. They also highlight the importance of including diverse patient populations in clinical trials, particularly those disproportionately affected by PAD, such as African Americans, Latinos, Native Americans, and women. This inclusive approach not only ensures the treatment's effectiveness across varied demographics but also sets a precedent for future trials. Thank you to Freudenberg Medical for sponsoring this episode of AbbottTalks. For more information on how Freudenberg Medical works with medical device companies, visit www.freudenbergmedical.com. Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.

Hear Kandu’s mission to empower stroke survivors, Medtronic’s Goodheart on lifting women in MedTech

2024-09-1301:01:20

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi chats with Managing Editor Kayleen Brown about the upcoming DeviceTalks West meeting. This week’s episode features an interview Brown did with Medtronic’s Nina Goodheart at the Women in Medtech Breakfast at DeviceTalks Boston. The conversation previews the Women in Medtech Luncheon interview featuring Cecilia Soriano, president, infusion therapies and technologies, at Baxter International. In our second interview, Salemi interviews Kirsten Carroll, CEO of Kandu Health about that company’s work to empower stroke survivors. Carroll will be speaking at DeviceTalks West. Register at West.DeviceTalks.com to register. Use the code DTPOD25 to save 25%. Subscribe now to the DeviceTalks Podcast Network.

Boston Scientific’s Baker on how Intracept battles back pain. Hear full story at DeviceTalks West

2024-09-0701:00:45

In this episode of DeviceTalks Weekly podcast, Host Tom Salemi introduces one DeviceTalks West speaker. Ray Baker, MD, vice president and chief medical officer, neuromodulation at Boston Scientific, introduces DeviceTalks Weekly listeners to Intracept, a procedure approved by the FDA to treat forms of back pain. Dr. Baker will be a speaker at DeviceTalks West on Oct. 17 where the clinical and commercial details will be discussed. Register now at West.Devicetalks.com. Use the code mentioned in the podcast to save 25% off the price of registration. Salemi also invites listeners to attend the Connected Health Series taking place Sept. 10-12. Sponsored by Maxon and S3 Connected Health, virtual attendees can hear from Adona Medical, Baxter, BD and Canary Medical about the future of sensors and other connected technologies. MassDevice Editor Chris Newmarker brings another batch of Newmarker’s Newsmakers including Novocure, Medtronic, Johnson & Johnson MedTech, Edwards Lifesciences and the Big 100. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Hear HighRidge Medical’s plans to scale the spine market; a preview of the MedtechVISION conference

2024-08-3001:05:38

In this episode of the DeviceTalks Weekly podcast, HighRidge Medical CEO Rebecca Whitney and Executive Chairman Eric Major introduce us to the spine industry’s newest player. HighRidge combines the former spinal business of Zimmer Biomet (and later ZimVie) with seasoned executive spirit from K2M, Stryker and others. Can HighRidge compete? Will robotics and other tech be part of the story? Whitney has been on podcasts before. Listen here https://www.youtube.com/watch?v=6xtHK-FVeec and here https://youtu.be/0Ve_7NpIauQ?si=Wp-ytFHlq4ZWHeCC. Host Tom Salemi and DeviceTalks Editor Kayleen Brown chat with MedtechVISION co-chairs Kate Stephenson, PhD, and Shelia Shah about the upcoming conference organized by the MedtechWOMEN group. A few spaces are still available. Go to MedtechWOMEN.org to register. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

GE HealthCare’s Samset on how deal led to building Caption AI for Vscan and securing FDA approval

2024-08-2758:031

In this episode of DeviceTalks AI, host Kayleen Brown sits down with Eigil Samset, PhD, General Manager for Cardiology Care at GE HealthCare. Dr. Samset takes us through his vast experience stretching over nearly three decades and discusses the transformative role of AI in advancing healthcare, particularly how GE HealthCare is leveraging AI to streamline and enhance cardiology care pathways. In the episode, Dr. Samset gives us the backstory of the 2023 Caption Health acquisition and provides insights into the inspiration behind Caption AI for use in Vscan, which democratizes cardiac assessments by making them accessible to less experienced users. The conversation touches on the regulatory challenges, the importance of multi-disciplinary collaboration, and GE HealthCare's strategic approach to integrating AI – aiming to improve patient outcomes and care pathways significantly. This conversation comes to you courtesy of our episode sponsor, DeviceTalks West. Listen to the episode for 25% OFF the registration rate: West.DeviceTalks.com. Please subscribe to DeviceTalks AI on all major podcast channels and subscribe to DeviceTalks on YouTube to ensure you never miss an episode. Thank you for listening to DeviceTalks AI!

How Dohadwala uses analytics, her gut, and the benefits of diversity to build a strong VC portfolio

2024-08-2301:11:57

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi talks with Tasneem Dohadwala, founding partner at Excelestar Ventures about how the small firm employs analytics, know-how, and a belief that companies are best led by diverse management teams. MassDevice Editor Chris Newmarker returns with his Newmarker's Newsmakers including outgoing FDA CDRH Leader Jeff Shuren, the New York Times, Medtronic, Zoll Medical, Vyaire Medical, Johnson & Johnson MedTech, V-Wave, and Edwards Lifesciences. This episode is sponsored by DeviceTalks West. Listen to the podcast to hear the discount code that will save you 25% of the price of registration. Go to West.DeviceTalks.com. We’ll also hear a message from regulatory firm MedTech Impact Partners. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network.

ZB’s Lancaster talks next-gen knee systems, robotics and building a new MedTech regional powerhouse

2024-08-2141:08

In this episode of Ortho Innovation Talks, Jim Lancaster, President of Global Reconstruction at Zimmer Biomet, connects his deep roots in Warsaw, Indiana—known as the orthopedic capital of the world—with his current role in shaping the region's future as a global MedTech hub with his efforts to diversify the region's medtech industry, including the partnership with Plug and Play to attract new innovations in sensor technology and augmented reality, and by driving technical innovations at Zimmer Biomet. Additionally, Lancaster provides an in-depth look at the development of Persona IQ, the world's first smart knee system, which integrates advanced sensor technology to monitor patient recovery. He also discusses the growing importance of cementless fixation in knee implants, highlighting Zimmer Biomet's focus on enhancing implant longevity and patient outcomes. Lastly, Lancaster discusses Zimmer Biomet's role in surgical robotics, particularly the advancements brought by the Rosa robotics platform, which includes applications for knee, hip, and even shoulder surgeries. Please join us September 10-12th for DeviceTalks's LIVE Connected Health webinar series. Register at no cost: https://event.on24.com/wcc/r/4613481/E930EFFA706588C378BEAA97824C7CE2/5516160 Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode. Thank you for listening to the Ortho Innovation Talks podcast, featuring Zimmer Biomet!

Daveen Chopra discusses Edwards’ mitral and tricuspid focus, PASCAL and EVOQUE, and patient impacts

2024-08-1636:58

In the inaugural episode of our newest podcast, Structural Heart Talks, we sit down with Daveen Chopra, Corporate VP and GM of Transcatheter Mitral and Tricuspid Therapies (TMTT) at Edwards Lifesciences. In the episode, Chopra discusses the unique challenges of advancing therapies for the mitral and tricuspid valves, which have historically been more difficult to treat than the aortic valve due to their complex and varied nature. He details Edwards Lifesciences' efforts to innovate in this space with technologies like the PASCAL valve repair system and the EVOQUE tricuspid valve replacement system, the first transcatheter tricuspid valve replacement approved in both the US and Europe. Later, Chopra explains the importance of a focused approach at Edwards Lifesciences, where the company’s specialization in structural heart disease enables deeper knowledge and more targeted innovation. The conversation also explores the intricate process of planning and executing these advanced procedures, which require close collaboration between interventional cardiologists and echocardiographers. Chopra underscores the ongoing commitment to clinical evidence and real-world outcomes as key drivers of future success in this rapidly evolving field. Looking ahead, he emphasizes the need to increase awareness, diagnosis, and treatment rates for valve diseases, noting that many patients still go untreated due to a lack of awareness. Thank you to Resonetics for sponsoring this episode of Structural Heart Talks. To learn more about how Resonetics supports medical device companies, visit: https://shorturl.at/E1wO8 Thank you for listening to the Structural Heart Talks podcast. Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks or the Structural Heart Talks on YouTube Podcasts to ensure you never miss an episode.

May Health VC and CEO give glimpse into promising startup, assessment of women’s health investments

2024-08-0901:04:39

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi delves into the opportunities in women’s health devices with Sofinnova Partners Managing Partner Antoine Papiernik and May Health CEO Anne Morrissey. Sofinnova invested in May Health, which is developing a device-based therapy for Polycystic ovary syndrome, a common cause of infertility. Is the financing environment for Women’s Health companies improving? What will drive investors to commit more capital. MassDevice Editor Chris Newmarker brings his Newmarker’s Newsmakers back featuring news from NeuroOne, Pentax, Allurion, Medtronic and Abbott. Associate Editor Sean Whooley joins the NewNew team to break down the new partnership between Abbott and Medtronic in the diabetes business. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe now to the DeviceTalks Podcast Network.

Intuitive CMO Myriam Curet unpacks DaVinci 5 launch, growing robotics adoption, and clinical impact

2024-08-0640:45

In this episode of IntuitiveTalks, we welcome back Myriam Curet, MD, EVP & Chief Medical Officer at Intuitive, to discuss the transformative impact of surgical robotics on patient care, focusing on the evolution of the DaVinci system, including the recent DaVinci 5 launch. In the episode, Dr. Curet explains how surgical robotics like DaVinci have shifted from being seen as advanced technology to becoming an integral part of surgical practice, enhancing patient outcomes and surgeon efficiency. She also stresses the significance of real-world data and meta-analyses in validating surgical robotic systems and providing a profound understanding of their benefits across various categories of surgery. Lastly, Dr. Curet offers a behind-the-scenes look at the meticulous development and approval process of the DaVinci 5 system. Thank you to Paragon Medical for sponsoring this episode of IntuitiveTalks. Please visit https://www.paragonmedical.com/ to learn more about how Paragon Medical supports medical device companies. Thank you for listening to the IntuitiveTalks podcast. Please subscribe to DeviceTalks on all major podcast channels to never miss an episode.

How can the cloud and connected devices improve patient care? Insulet CEO Jim Hollingshead knows

2024-08-0201:16:47

In this episode of DeviceTalks Weekly Podcast, Host Tom Salemi interviews Jim Hollingshead, PhD, the CEO of Insulet. Hollingshead had the unenviable job of taking over for CEO Shacey Petrovic when she left the insulin-delivery company two years ago. Hollingshead previously had helped ResMed develop its industry-leading connectivity/cloud strategy. In this conversation you’ll hear about his journey and what steps Insulet has taken to build share in the Type 1 and Type 2 diabetes markets MassDevice Editor Chris Newmaker returns with his newsmakers - Asensus Surgical, Tandem, Stryker, Perceptive, and BiVacor. This episode is sponsored by DeviceTalks West. Register to attend at West.DeviceTalks.com Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don't miss a future episode.

New CEO Landon on the power of mentorship and the strategy behind expanding Natus Neuro DX platform

2024-07-2656:36

In this episode of the DeviceTalks Weekly, Chris Landon returns to the podcast but this time as CEO of Natus Neuro, a company building out a monitoring, diagnostics and data collection platform to help diagnose and treat neurological disorders. This episode is sponsored by DeviceTalks West. Host Tom Salemi and Chris Newmarker, editor of MassDevice, review this week’s Newmaker’s Newsmakers - aka the week’s biggest medtech stories. Top newsmakers include Imperative Care, the FDA, neuro start-Ups, Inspire Medical and Edwards Lifesciences. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe now to the DeviceTalks Podcast Network.

Abbott’s Fishler on Dual Chamber Leadless Pacemaker from “submarine” tests to FDA approval

2024-07-2341:40

In this episode of AbbottTalks, Matthew Fishler, PhD, Chief Engineer & Senior Director, Product Development, Cardiac Rhythm Management at Abbott Cardiovascular, shares his experience helping to develop the revolutionary dual-chamber leadless pacemaker system, taking us through the significant challenges and triumphs of creating a device that ensures precise coordination between the heart’s atrial and ventricular chambers without traditional leads. Fishler recounts the meticulous development process, from initial concept testing using rudimentary "submarines" in saline tanks to achieving FDA approval. He highlights the deliberate approach taken to ensure safety and effectiveness, resulting in a device that now benefits patients with more comprehensive cardiac support. Lastly, he explains the innovative i2i communication technology, which uses electrical impulses to enable seamless device interaction, a concept likened to a “moonshot” due to its unprecedented nature. Thank you to ProMed for sponsoring this episode of AbbottTalks. To learn more about ProMed’s prototype services, visit: https://promedmolding.com/capabilities/prototyping/ Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.

CEO Rowland shares how Endotronix will bring hope to heart patients following FDA Cordella approval

2024-07-1901:00:43

In this week’s DeviceTalks Weekly Podcast, Host Tom Salemi talks with Endotronix CEO Harry Rowland about the company’s long road to securing PMA approval from the FDA for its Cordella Pulmonary Artery (PA) Sensor System for the treatment of heart failure patients. But first we welcome back the Newmarker’s Newsmakers! MassDevice Editor-in-Chief Chris Newmarker highlights news from Masimo, Stryker, Medtronic, ICU Medical and Edwards Lifescience. This episode is sponsored by DeviceTalks West. Register to attend at West.DeviceTalks.com. Thank you for listening to the DeviceTalks Weekly podcast. Subscribe now to the DeviceTalks Podcast Network.

#box-pro-ellipsis-172916040710157{-webkit-line-clamp:2;}DeviceTalks Podcast Network